GDTC CytoMed Therapeutics
- 2.160
- +0.150+7.46%
- 2.120
- -0.040-1.85%
CytoMed Therapeutics News
CytoMed Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Glorious Finance Limited(38.89%),Choo Chee Kong(26.57%)
CytoMed Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-mDR Limited(11.59%)
CytoMed Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Zeng Jieming(5.11%)
CytoMed Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-mDR Limited(11.60%)
CytoMed Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Glorious Finance Limited(42.54%),Choo Chee Kong(28.86%)
CytoMed Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Loh Yuin Han
CytoMed Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Leong Mark Kei Wei
CytoMed Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Zeng Jieming
CytoMed Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Toh Keng Kiat
CytoMed Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Choo Chee Kong
CytoMed Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Luk Lucas Tien Wee
CytoMed Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Yew Chak Hua
CytoMed Therapeutics | 3: Initial statement of beneficial ownership of securities-Chief Operating Officer Tan Wee Kiat
CytoMed Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Wang Shu
CytoMed Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Glorious Finance Ltd
Analysis
Price Target
No Data
